Literature DB >> 2356873

CSF oxytocin in anorexia nervosa and bulimia nervosa: clinical and pathophysiologic considerations.

M A Demitrack1, M D Lesem, S J Listwak, H A Brandt, D C Jimerson, P W Gold.   

Abstract

Oxytocin is a hypothalamic neuropeptide with both centrally and peripherally directed pathways. Data from experimental animals indicate that oxytocin impairs consolidation of aversively conditioned behaviors and is released after feeding or experimental gastric distension. The authors report that the mean CSF oxytocin level of five underweight women with restricting anorexia, but not 12 underweight bulimic anorexic women or 35 normal-weight women with bulimia nervosa, was significantly lower than the level of 11 control subjects. Restricting anorexic patients' low CSF oxytocin levels may reflect their persistently low food intake, and this behavior may exacerbate their tendency for perseverative preoccupation with adverse consequences of food intake.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2356873     DOI: 10.1176/ajp.147.7.882

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  24 in total

Review 1.  Psychopharmacotherapy of anorexia nervosa, bulimia nervosa and binge-eating disorder.

Authors:  S Krüger; S H Kennedy
Journal:  J Psychiatry Neurosci       Date:  2000-11       Impact factor: 6.186

Review 2.  Is anorexia nervosa a neuropsychological disease?

Authors:  C M Braun; M J Chouinard
Journal:  Neuropsychol Rev       Date:  1992-06       Impact factor: 7.444

3.  Low Fasting Oxytocin Levels Are Associated With Psychopathology in Anorexia Nervosa in Partial Recovery.

Authors:  Yuliya Afinogenova; Cindy Schmelkin; Franziska Plessow; Jennifer J Thomas; Reitumetse Pulumo; Nadia Micali; Karen K Miller; Kamryn T Eddy; Elizabeth A Lawson
Journal:  J Clin Psychiatry       Date:  2016-11       Impact factor: 4.384

4.  Autoantibodies against neuropeptides are associated with psychological traits in eating disorders.

Authors:  Sergueï O Fetissov; Jaanus Harro; Maiken Jaanisk; Anu Järv; Iris Podar; Jüri Allik; Ida Nilsson; Priya Sakthivel; Ann Kari Lefvert; Tomas Hökfelt
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-29       Impact factor: 11.205

Review 5.  The Neuropeptide Hormone Oxytocin in Eating Disorders.

Authors:  Franziska Plessow; Kamryn T Eddy; Elizabeth A Lawson
Journal:  Curr Psychiatry Rep       Date:  2018-09-04       Impact factor: 5.285

6.  Decreased nocturnal oxytocin levels in anorexia nervosa are associated with low bone mineral density and fat mass.

Authors:  Elizabeth A Lawson; Daniel A Donoho; Justine I Blum; Erinne M Meenaghan; Madhusmita Misra; David B Herzog; Patrick M Sluss; Karen K Miller; Anne Klibanski
Journal:  J Clin Psychiatry       Date:  2011-08-09       Impact factor: 4.384

Review 7.  Emerging Treatments in Eating Disorders.

Authors:  Michael Lutter
Journal:  Neurotherapeutics       Date:  2017-07       Impact factor: 7.620

8.  Disrupted Oxytocin-Appetite Signaling in Females With Anorexia Nervosa.

Authors:  Anna Aulinas; Franziska Plessow; Reitumetse L Pulumo; Elisa Asanza; Christopher J Mancuso; Meghan Slattery; Christiane Tolley; Jennifer J Thomas; Kamryn T Eddy; Karen K Miller; Anne Klibanski; Madhusmita Misra; Elizabeth A Lawson
Journal:  J Clin Endocrinol Metab       Date:  2019-10-01       Impact factor: 5.958

9.  Adiponectin selectively inhibits oxytocin neurons of the paraventricular nucleus of the hypothalamus.

Authors:  Ted D Hoyda; Mark Fry; Rexford S Ahima; Alastair V Ferguson
Journal:  J Physiol       Date:  2007-10-18       Impact factor: 5.182

Review 10.  The effects of oxytocin on eating behaviour and metabolism in humans.

Authors:  Elizabeth A Lawson
Journal:  Nat Rev Endocrinol       Date:  2017-09-29       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.